Register Today for this Free Webinar Series!

Industry interest in continuous bioprocessing is rapidly increasing, yet questions remain about best practices for effective integration. In 2016, Pall Life Sciences delivered on a promise to bring novel continuous solutions to the market, while sharing the hows and whys of transitioning from batch to semi- and fully-continuous bioprocesses.

In the first part of this webinar series, key customers align with our team to highlight the advantages of continuous operations, and how novel technologies, such as continuous multi-column chromatography, are already impacting drug development.

Already Registered? Log In Now

Complete this form to enter the webcast.
(* indicates required field)

  • Yes
  • No
  • Yes
  • No
  • Vaccines
  • Antibody Drug Conjugates
  • Gene Therapy
  • Cell Therapy
  • Biotechnology
  • Chemical API/Antibiotics
  • Plasma/Biologicals
  • Formulation and Filling
  • Utilities (gas, air & water)
  • CMO
  • Other
  • Cell Culture / Fermentation
  • Clarification / Cell Removal
  • Concentration / Diafiltration
  • Purification
  • Viral Clearance
  • Continuous Processing
  • Single-Use Technologies
  • Formulation and Filling
  • QC / Analytics
  • Other